Classification
- Anatomical main groupLAntineoplastic and immunomodulating agents
- Therapeutic subgroupL01Antineoplastic agents
- Pharmacological subgroupL01B
- Chemical subgroupL01BA
- Chemical substanceL01BA01Methotrexate
L04AX03
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Netherlands
CBG-MEB · 140 registrations
- Basitrin 10 mg=0,267 ml, oplossing voor injectie in een voorgevulde spuit 37,5 mg/mlOplossing voor injectie · Basic Pharma Manufacturing B.V.
- Basitrin 12,5 mg=0,333 ml, oplossing voor injectie in een voorgevulde spuit 37,5 mg/mlOplossing voor injectie · Basic Pharma Manufacturing B.V.
- Basitrin 15 mg=0,400 ml, oplossing voor injectie in een voorgevulde spuit 37,5 mg/mlOplossing voor injectie · Basic Pharma Manufacturing B.V.
- Basitrin 17,5 mg=0,467 ml, oplossing voor injectie in een voorgevulde spuit 37,5 mg/mlOplossing voor injectie · Basic Pharma Manufacturing B.V.
At a glance
- ATC code
- L01BA01, L04AX03
- Registers
- 11
- Historical lists
- 2
- Registrations
- 477
- With their own page
- 358
- Companies
- 107
All medicines with Methotrexate
Human medicines from every register that match Methotrexate by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
478 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Methotrexate | Canada | 2.5 MG | Tablet | Authorised | Apotex INC |
| Methotrexate | United States | 5GM/50ML | solution | Not marketed | Accord Hlthcare |
| Methotrexate Sodium | United States | 100MG BASE/4ML, 100MG BASE/VIAL, 1GM BASE/40ML … | Injectable | Marketed | Quad Pharms |
| Methotrexate Sodium | United States | 2.5MG BASE, 2.5MG BASE | tablet | Marketed | Sun Pharm |
| Methotrexate LPF | United States | 25MG BASE/ML | injectable | Not marketed | Hospira |
| Methotrexate DBL | New Zealand | Inj 2.5 mg per ml, 2 ml | Funded | ||
| Methotrexate Pfizer | Serbia | 500mg/20mL | rastvor za injekciju | Authorised | Pfizer SRB D.O.O. |
| Methotrexate Pfizer | Serbia | 50mg/2mL | rastvor za injekciju | Authorised | Pfizer SRB D.O.O. |
| Methotrexate Preservative Free | United States | 1GM BASE/VIAL, 2.5GM BASE/100ML, 20MG BASE/2ML … | injectable | Marketed | Fresenius Kabi USA |
| Methotrexate Ebewe | New Zealand | Inj 100 mg per ml, 50 ml vial | Funded | ||
| Methotrexate Ebewe | New Zealand | Inj 100 mg per ml, 10 ml vial | Funded | ||
| Methotrexate Ebewe | New Zealand | Inj 100 mg per ml, 10 ml | Funded | ||
| Methotrexate Tablets, USP | Canada | 10 MG | Tablet | Marketed | Pfizer Canada Ulc |
| Methotrexate Sandoz | New Zealand | Inj 25 mg prefilled syringe | Funded | ||
| Methotrexate Sandoz | New Zealand | Inj 20 mg prefilled syringe | Funded | ||
| Methotrexate Sandoz | New Zealand | Inj 30 mg prefilled syringe | Funded | ||
| Methotrexate Sandoz | New Zealand | Inj 10 mg prefilled syringe | Funded | ||
| Methotrexate Sandoz | New Zealand | Inj 7.5 mg prefilled syringe | Funded | ||
| Methotrexate Sandoz | New Zealand | Inj 15 mg prefilled syringe | Funded | ||
| Methotrexate Injection, BP | Canada | 25 MG / ML | Solution | Marketed | Pharmascience INC |
| Methotrexate Injection, BP | Canada | 7.5 MG / 0.3 ML | Solution | Marketed | Pharmascience INC |
| Methotrexate Injection, BP | Canada | 10 MG / 0.4 ML | Solution | Marketed | Pharmascience INC |
| Methotrexate Injection BP | Canada | 25 MG / ML | Solution | Marketed | Accord Healthcare INC |
| Methotrexate Injection BP | Canada | 25 MG / ML | Solution | Marketed | Accord Healthcare INC |
| Methotrexate Injection, BP | Canada | 15 MG / 0.6 ML | Solution | Marketed | Pharmascience INC |



